# A Study of Real-world Cohort of Pulmonary Arterial Hypertension (PAH) Participants

Study · id `cardio:ct-nct04955990` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04955990](<https://clinicaltrials.gov/study/NCT04955990>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT04955990

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 232 participants.

## Technical summary

Registry record NCT04955990. Allocation not applicable; no masking; primary purpose other. Start 2021-10-14 (actual); primary completion 2022-12-20 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose other
- Phase: Phase 4
- Enrolled: 232 participants (enrolled count; ClinicalTrials.gov record NCT04955990, source copy `cardio:ctgov-nct04955990-2025-02-03`, retrieved 2026-10-31)
- Started: 2021-10-14 (actual) (ClinicalTrials.gov record NCT04955990, source copy `cardio:ctgov-nct04955990-2025-02-03`, retrieved 2026-10-31)
- Primary completion: 2022-12-20 (actual) (ClinicalTrials.gov record NCT04955990, source copy `cardio:ctgov-nct04955990-2025-02-03`, retrieved 2026-10-31)
- Completion: 2022-12-20 (actual) (ClinicalTrials.gov record NCT04955990, source copy `cardio:ctgov-nct04955990-2025-02-03`, retrieved 2026-10-31)
- Countries: United States; Argentina; Brazil; Canada; China; Germany; Italy; Japan; Malaysia; Netherlands; Poland; Puerto Rico; Singapore; South Korea; Spain; Sweden; United Kingdom (ClinicalTrials.gov record NCT04955990, source copy `cardio:ctgov-nct04955990-2025-02-03`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04955990-2025-02-03`, retrieved 2026-10-31)

## The registry's words

- Brief title: A Study of Real-world Cohort of Pulmonary Arterial Hypertension (PAH) Participants
- Acronym: CARE PAH
- Condition: Pulmonary Arterial Hypertension
- Intervention (Other): PAH Therapies
- Lead sponsor: Actelion
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Pulmonary arterial hypertension (`cardio:pulmonary-arterial-hypertension`)
- Registry condition terms include this condition: Pulmonary hypertension (`cardio:pulmonary-hypertension`)
- Registry lists this organization as the lead sponsor: Actelion (`cardio:org-actelion`)

## Provenance

Content hash: 8c4fb86995cc30701d252bad7cefbdf54f3501936e5c5977d3b0c58c851aa7fb
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
